Screener
Travere Therapeutics, Inc. TVTX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 3,627 | 4,022 |
| Operating lease right of use assets | 9,668 | 10,576 |
| Intangible assets, net | 110,038 | 113,868 |
| Other assets | 8,476 | 8,880 |
| Total assets | $555,188 | $605,191 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $12,912 | $24,800 |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s other non-current assets?
- Travere Therapeutics, Inc. (TVTX) reported other non-current assets of $8.48M in Q1 2026.
- How has Travere Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Travere Therapeutics, Inc.'s other non-current assets decreased by 54.6% year-over-year, from $18.69M to $8.48M.
- What is the long-term trend for Travere Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s other non-current assets has grown at a 2.6% compound annual growth rate (CAGR), from $7.81M to $8.88M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Travere Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude